Abstract

Adrenal Fatigue

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2013 - Volume 17, Number 1

Page(s): 39-44

Download in electronic PDF format for $75

Abstract

This article discusses the function of the adrenal gland and adrenal fatigue, to include the symptoms, possible causes, and treatment of adrenal fatigue. Compounding pharmacists can prepare formulations to assist the patient who is suffering from this syndrome. Included with this article are formulations which require a physician’s prescription, as well as nonprescription nutritional supplements.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2013 Pg. 39-44	Adrenal Fatigue Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 192-199	Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Author(s): Riepl Mike
Sep/Oct 2007 Pg. 384-388	Equine Cushing's Disease: A Clinical Update Author(s): Bliss George
Jan/Feb 2003 Pg. 27-29	Equine Cushing’s Syndrome Author(s): Vail Jane
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
May/Jun 2008 Pg. 230-233	Communication with Pharmacy Technicians: How to Reduce Stress and Improve Pharmacy Operations Author(s): Fyke Jeremy P, Hoffman Mary F
Jul/Aug 2005 Pg. 259-264 View Sample	Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome Author(s): Tan Robert S
Jan/Feb 2021 Pg. 18-23	Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol Author(s): McKettrick Greg, Yoch Doug
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Jan/Feb 2013 Pg. 74-85 View Sample	The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Sep/Oct 1999 Pg. 344-348	Wilson's Syndrome and T3 Therapy Author(s): Milner Martin
Jul/Aug 2020 Pg. 315	Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 153	Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet) Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 52-54	Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Author(s): Ford Gina, Garcia Lea
Nov/Dec 2010 Pg. 465-471	The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women Author(s): Bramwell Bethany L
Jul/Aug 2009 Pg. 280-288	Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation Author(s): Kells John, Dollbaum Charles M
Sep/Oct 2021 Pg. 431-439	Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Mar/Apr 2022 Pg. 150-154	Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Author(s): Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
Jul/Aug 2021 Pg. 325	Hydrocortisone 2-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 284-293	Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID Author(s): Riepl Mike, Kaiser Joe